Stock Taper Revenue: Approximately $4.5 million, a significant increase from the previous year.
Operating Loss: Improved to $41.3 million from $45.6 million year-over-year.
Net Loss: $142.2 million, slightly better than $144.2 million a year ago.
Adjusted EBITDA: Negative $31.7 million, compared to negative $27.8 million, reflecting lower non-cash add-backs.
Production: Produced approximately 4.5 million pounds of PureFive, down from the prior quarter due to a planned turnaround.
Liquidity: Total liquidity increased to $236.9 million, including $165.2 million in cash and cash equivalents.
Operational Improvements: Completed a major turnaround ahead of schedule and below budget, executing over 170 projects to enhance reliability and throughput.
New Records: Set a new daily throughput record of 12,000 pounds per hour in June.
Commercial Developments: First Procter & Gamble application entered commercial production; significant progress with quick-service restaurants (QSRs) and other major brands.
Regulatory Approvals: New Jersey approved PureFive as recycled content, accelerating qualification processes with customers.
International Expansion: Received Board of Investment approval for the Thailand facility, with plans to break ground in the second half of 2026.
Breakeven Target: Aiming for Ironton breakeven at 40-50% utilization in the second half of 2026.
Demand Forecast: Anticipating a ramp-up in demand driven by regulatory deadlines in January 2027, with expected sales of $40 million to $50 million outside New Jersey and $25 million to $50 million within New Jersey.
Production Expectations: Production levels are expected to rise in Q3 and Q4 as commercial activities ramp up.
Net Loss: Despite improvements, the net loss remains substantial, indicating ongoing financial challenges.
Adjusted EBITDA: Continued negative adjusted EBITDA reflects ongoing operational costs and challenges in scaling production.
Market Fragmentation: The market's structure requires numerous qualifications for various SKUs, which could slow down the ramp-up process.
Regulatory Risks: While regulatory approvals are progressing, compliance with evolving regulations remains a potential risk.
Thailand Project: Groundbreaking is expected in the second half of 2026, with financing discussions progressing towards a close by year-end.
P&G Relationship: The cadence of new applications with Procter & Gamble is accelerating, with confidence that other large brands will follow suit.
Production vs. Demand: Production levels are expected to increase in line with commercial demand, particularly as brands rush to meet regulatory deadlines.
Compounding Product Pricing: Pricing for compounded products remains strong, allowing for a premium over virgin resin, which enhances the value proposition for customers. Overall, PureCycle Technologies demonstrated operational progress and strategic advancements in Q2 2026, setting the stage for a potentially strong second half of the year, despite ongoing financial losses and market challenges.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT